Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedNov 08, 2025
DataAggregated Company Financials
Companies206
  • 7D0.8%
  • 3M6.2%
  • 1Y-4.9%
  • YTD1.9%

Over the last 7 days, the Healthcare industry has remained flat, although notably Chugai Pharmaceutical gained 5.9%. As for the longer term, the industry has declined 4.9% in the last year. As for the next few years, earnings are expected to grow by 10% per annum.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 08 Nov 2025JP¥66.9tJP¥38.3tJP¥2.8t15.4x24x1.7x
Mon, 06 Oct 2025JP¥65.1tJP¥38.2tJP¥2.7t15.6x24.3x1.7x
Wed, 03 Sep 2025JP¥64.4tJP¥38.2tJP¥2.7t15.9x24.1x1.7x
Fri, 01 Aug 2025JP¥64.7tJP¥38.0tJP¥2.7t15.3x24.1x1.7x
Sun, 29 Jun 2025JP¥62.5tJP¥38.1tJP¥2.6t14.5x23.6x1.6x
Tue, 27 May 2025JP¥63.0tJP¥38.1tJP¥2.6t14x23.8x1.7x
Thu, 24 Apr 2025JP¥62.6tJP¥37.5tJP¥2.4t14.5x26.1x1.7x
Sat, 22 Mar 2025JP¥63.8tJP¥37.5tJP¥2.4t15.1x26.7x1.7x
Mon, 17 Feb 2025JP¥64.4tJP¥37.5tJP¥2.4t15.1x26.9x1.7x
Wed, 15 Jan 2025JP¥65.8tJP¥36.5tJP¥2.2t16.7x29.6x1.8x
Fri, 13 Dec 2024JP¥67.8tJP¥36.7tJP¥2.2t16.3x30.2x1.8x
Sun, 10 Nov 2024JP¥71.1tJP¥36.7tJP¥2.3t17.4x31.6x1.9x
Tue, 08 Oct 2024JP¥70.7tJP¥36.0tJP¥2.0t17.8x35.6x2x
Thu, 05 Sep 2024JP¥71.6tJP¥36.0tJP¥2.0t17.6x36x2x
Sat, 03 Aug 2024JP¥66.8tJP¥35.6tJP¥1.9t16.7x34.5x1.9x
Mon, 01 Jul 2024JP¥67.3tJP¥35.3tJP¥1.9t17.7x36x1.9x
Wed, 29 May 2024JP¥64.8tJP¥35.3tJP¥1.9t17.4x34.7x1.8x
Fri, 26 Apr 2024JP¥62.7tJP¥34.7tJP¥2.0t17.2x32.1x1.8x
Sun, 24 Mar 2024JP¥68.7tJP¥35.1tJP¥2.0t18.5x35x2x
Tue, 20 Feb 2024JP¥67.3tJP¥35.1tJP¥2.0t18.7x34.4x1.9x
Thu, 18 Jan 2024JP¥66.2tJP¥35.0tJP¥2.2t17.9x30.7x1.9x
Sat, 16 Dec 2023JP¥62.5tJP¥35.0tJP¥2.2t17.8x29x1.8x
Mon, 13 Nov 2023JP¥61.5tJP¥35.0tJP¥2.1t17.4x28.7x1.8x
Wed, 11 Oct 2023JP¥62.5tJP¥34.5tJP¥2.3t17.7x27.5x1.8x
Fri, 08 Sep 2023JP¥64.3tJP¥34.5tJP¥2.3t18.3x28.4x1.9x
Sun, 06 Aug 2023JP¥63.1tJP¥34.3tJP¥2.3t18.9x27.8x1.8x
Tue, 04 Jul 2023JP¥65.9tJP¥33.9tJP¥2.3t18.7x28.4x1.9x
Thu, 01 Jun 2023JP¥63.8tJP¥33.9tJP¥2.3t17.9x27.6x1.9x
Sat, 29 Apr 2023JP¥62.0tJP¥33.5tJP¥2.3t17.2x27x1.9x
Mon, 27 Mar 2023JP¥59.1tJP¥33.5tJP¥2.3t16.7x25.7x1.8x
Wed, 22 Feb 2023JP¥59.6tJP¥33.5tJP¥2.3t17x25.9x1.8x
Fri, 20 Jan 2023JP¥59.2tJP¥32.4tJP¥2.2t15.9x27.2x1.8x
Sun, 18 Dec 2022JP¥63.4tJP¥32.4tJP¥2.2t15.8x29.2x2x
Tue, 15 Nov 2022JP¥63.4tJP¥32.4tJP¥2.2t15.5x29.1x2x
Price to Earnings Ratio

29.1x


Total Market Cap: JP¥63.4tTotal Earnings: JP¥2.2tTotal Revenue: JP¥32.4tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 29.1x202320242025
Current Industry PE
  • Investors are pessimistic on the Japanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 23.8x which is lower than its 3-year average PE of 29.1x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 8.5% per year over the last three years.
  • Revenues for these companies have grown 5.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market-0.98%
Healthcare0.85%
Life Sciences1.69%
Pharma1.51%
Healthcare Services1.06%
Medical Equipment0.0037%
Healthtech-2.85%
Biotech-3.17%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 76.7x.
    • Analysts are expecting annual earnings growth of 7.0%, which is higher than its past year's earnings growth of 5.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 28% over the next 5 years.
  • However this is lower than its past earnings growth rate of 47% per year.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 7.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4519 Chugai PharmaceuticalJP¥7.47k5.9%
+JP¥689.6b		3.1%PE30.9x
4503 Astellas PharmaJP¥1.75k8.6%
+JP¥248.9b		2.2%PE25.1x
4506 Sumitomo PharmaJP¥2.14k27.2%
+JP¥181.8b		264.9%PE5.5x
7741 HOYAJP¥25.44k1.4%
+JP¥120.8b		19.3%PE41.4x
4502 Takeda PharmaceuticalJP¥4.18k0.7%
+JP¥42.6b		-0.9%PE199.6x

Latest News

4503
JP¥1,752.50
Astellas Pharma
7D
8.6%
1Y
2.2%

Astellas Pharma's (TSE:4503) Earnings May Just Be The Starting Point

Nov 07
Astellas Pharma's (TSE:4503) Earnings May Just Be The Starting Point
4592
JP¥2,473.00
SanBio
7D
-12.6%
1Y
129.0%
4523
JP¥4,387.00
Eisai
7D
-4.0%
1Y
-13.6%

4523: Upcoming Regulatory Approvals And Product Launches Will Drive Shares Higher

Narrative Update on Eisai: Analyst Price Target Revision Analysts have maintained their price target for Eisai at ¥5,026.92, citing slightly stronger revised revenue growth forecasts and a modest increase in the discount rate as underlying factors in their valuation assessment. What's in the News Health Canada issued a Notice of Compliance with conditions for LEQEMBI® (lecanemab), making it the first treatment for early Alzheimer's disease that targets an underlying cause to be authorized in Canada.
4506
JP¥2,142.00
Sumitomo Pharma
7D
27.2%
1Y
264.9%
4502
JP¥4,180.00
Takeda Pharmaceutical
7D
0.7%
1Y
-0.9%

4502: Sustained Clinical Momentum And Management Transition Will Drive Future Upside

Narrative Update: Takeda Pharmaceutical Analyst Price Target Revision Analysts have slightly reduced their price target for Takeda Pharmaceutical, lowering it from ¥4,950 to ¥4,906. This change reflects modest adjustments in forecasted revenue growth and profit margin expectations.
6869
JP¥1,637.50
Sysmex
7D
-5.2%
1Y
-47.8%
4568
JP¥3,368.00
Daiichi Sankyo Company
7D
-8.2%
1Y
-30.8%

Earnings Beat: Here's What Daiichi Sankyo Company, Limited (TSE:4568) Analysts Are Forecasting For This Year

Nov 04
Earnings Beat: Here's What Daiichi Sankyo Company, Limited (TSE:4568) Analysts Are Forecasting For This Year
7733
JP¥1,871.50
Olympus
7D
-1.5%
1Y
-29.6%

7733: Market Will Weigh Product Recall Against Modest Guidance Revision Risk

Narrative Update: Analyst Price Target for Olympus Adjusted Analysts have slightly reduced their fair value estimate for Olympus, lowering the price target from $1,976.43 to $1,951.54. The change is attributed to updated expectations for discount rates and revenue growth.
7741
JP¥25,440.00
HOYA
7D
1.4%
1Y
19.3%

Earnings Beat: HOYA Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 03
Earnings Beat: HOYA Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
4151
JP¥2,421.50
Kyowa Kirin
7D
1.7%
1Y
-7.4%
4528
JP¥1,928.50
Ono Pharmaceutical
7D
2.8%
1Y
1.2%

Analysts Have Made A Financial Statement On Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Half-Year Report

Nov 01
Analysts Have Made A Financial Statement On Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Half-Year Report
4507
JP¥2,607.00
Shionogi
7D
1.0%
1Y
20.8%
4519
JP¥7,468.00
Chugai Pharmaceutical
7D
5.9%
1Y
3.1%

Chugai Pharmaceutical (TSE:4519) Has Announced A Dividend Of ¥125.00

Oct 29
Chugai Pharmaceutical (TSE:4519) Has Announced A Dividend Of ¥125.00
6849
JP¥1,697.50
Nihon Kohden
7D
-4.8%
1Y
-23.9%

What You Can Learn From Nihon Kohden Corporation's (TSE:6849) P/E

Oct 23
What You Can Learn From Nihon Kohden Corporation's (TSE:6849) P/E
4483
JP¥4,510.00
JMDC
7D
-8.0%
1Y
3.1%

Is Now The Time To Put JMDC (TSE:4483) On Your Watchlist?

Oct 22
Is Now The Time To Put JMDC (TSE:4483) On Your Watchlist?
2413
JP¥2,104.50
M3
7D
-3.0%
1Y
50.9%